The large variations in the recorded incidence of prostate cancer between countries are partly related to health-system factors linked to social and economic development and diagnostic practices such as the extent to which prostate-specific antigen (PSA) is used.5 The underlying variations in incidence are poorly understood because most research into the genetics and epidemiology of prostate cancer has been done in White populations. Here, KLK3 is linked to prostate carcinoma.